In a multitude of human clinical studies [32,35,36,37,38,39,40], elevated CRP levels post-myocardial infarction have been shown to be associated with larger infarct size, development of heart failure, adverse LV remodelling, and MVO as evaluated by CMR. The gene discussed is CRP; the disease is heart failure.